FGL1 and malignant colon neoplasm: FGL1 may be present as an oncogene in colon cancer, in FGL1-knockout mouse models implanted with MC38 colon cancer cells, the growth rate of colon cancer cells was significantly reduced compared to the control group, and the application of anti-FGL1 monoclonal antibodies showed favorable antitumor effects [30].